- Home
- ABEO vs FRGE Comparison
ABEO vs FRGE Comparison
Compare ABEO & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | FRGE |
|---|---|---|
| Founded | 1974 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 615.4M |
| IPO Year | 1980 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | FRGE |
|---|---|---|
| Price | $5.46 | $44.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $18.20 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 1.2M | 266.8K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | $400,000.00 | ★ $92,884,000.00 |
| Revenue This Year | N/A | $33.10 |
| Revenue Next Year | $1,589.77 | $24.07 |
| P/E Ratio | $4.24 | ★ N/A |
| Revenue Growth | N/A | ★ 16.40 |
| 52 Week Low | $3.93 | $6.60 |
| 52 Week High | $7.54 | $44.76 |
Technical Indicators
Market Signals| Indicator | ABEO | FRGE |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 81.62 |
| Support Level | $4.80 | $44.27 |
| Resistance Level | $5.55 | $44.75 |
| Average True Range (ATR) | 0.26 | 0.18 |
| MACD | 0.04 | -0.60 |
| Stochastic Oscillator | 80.75 | 98.96 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.